Indogulf Cropsciences Ltd
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]
- Market Cap ₹ 474 Cr.
- Current Price ₹ 74.7
- High / Low ₹ 122 / 49.5
- Stock P/E 11.9
- Book Value ₹ 72.6
- Dividend Yield 0.00 %
- ROCE 12.2 %
- ROE 10.9 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.03 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 9.73% over past five years.
- Company has a low return on equity of 12.1% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 443 | 486 | 550 | 552 | 590 | 705 | |
| 404 | 442 | 501 | 493 | 526 | 631 | |
| Operating Profit | 39 | 45 | 49 | 59 | 64 | 74 |
| OPM % | 9% | 9% | 9% | 11% | 11% | 10% |
| 2 | 4 | 3 | -0 | 5 | 8 | |
| Interest | 5 | 6 | 12 | 13 | 15 | 17 |
| Depreciation | 6 | 8 | 10 | 10 | 11 | 11 |
| Profit before tax | 30 | 36 | 30 | 36 | 45 | 53 |
| Tax % | 26% | 26% | 26% | 22% | 29% | 25% |
| 22 | 26 | 22 | 28 | 31 | 40 | |
| EPS in Rs | 9.48 | 11.25 | 9.53 | 12.00 | 6.45 | 6.33 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 21% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 12% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 49 | 63 |
| Reserves | 130 | 157 | 180 | 208 | 226 | 396 |
| 79 | 102 | 195 | 159 | 227 | 183 | |
| 178 | 139 | 120 | 154 | 188 | 181 | |
| Total Liabilities | 411 | 421 | 519 | 544 | 690 | 823 |
| 51 | 53 | 69 | 48 | 47 | 49 | |
| CWIP | 6 | 9 | 9 | 23 | 58 | 76 |
| Investments | 3 | 0 | 0 | 0 | 0 | 12 |
| 351 | 359 | 440 | 474 | 585 | 687 | |
| Total Assets | 411 | 421 | 519 | 544 | 690 | 823 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 20 | -7 | -57 | 53 | -15 | -41 | |
| -10 | -10 | -19 | -5 | -40 | -37 | |
| -9 | 16 | 75 | -49 | 61 | 80 | |
| Net Cash Flow | 1 | -1 | -1 | -1 | 7 | 3 |
| Free Cash Flow | 10 | -19 | -77 | 47 | -55 | -69 |
| CFO/OP | 72% | 6% | -95% | 100% | -5% | -36% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 97 | 115 | 117 | 146 | 138 | 125 |
| Inventory Days | 205 | 167 | 201 | 195 | 260 | 258 |
| Days Payable | 138 | 111 | 79 | 109 | 129 | 96 |
| Cash Conversion Cycle | 164 | 171 | 239 | 232 | 268 | 286 |
| Working Capital Days | 62 | 86 | 91 | 111 | 114 | 158 |
| ROCE % | 16% | 12% | 13% | 13% | 12% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| New Product Launches count |
|
||||
| Capacity Utilization % |
|||||
| Distributors (B2C) count |
|||||
| Export Countries count |
|||||
| Institutional Business Partners (B2B) count |
|||||
| Product Registrations count |
|||||
| Products Portfolio count |
|||||
Extracted by Screener AI
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Jul
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
9 Jul - MD Sanjay Aggarwal received the 17th Visionary Leadership Award 2026 on 8 July 2026.
-
Closure of Trading Window
24 Jun - Trading window closed from July 1, 2026 for Q1 FY2027 unaudited results approval.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Jun - Indogulf Cropsciences Limited has informed regarding the meet with analysts and investors in one-on-one and group meetings, on Thursday, 18 June & Friday, 19th June …
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2 Jun - Submission of the Transcript of Q4 FY 2025-26 Earning Conference Call held on May 29, 2026
Annual reports
Concalls
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.